Clinical outcomes and complication rates following medial collateral ligament reconstruction using Achilles tendon allograft or hamstring tendon autograft: A systematic review.

IF 5
Ross Sian, Abbas See, Tawfiq Alqeisi, Amit Meena, Stephen Dalgleish, Darren de Sa, Peter Davies, Peter D'Alessandro, Jimmy Ng, Shahbaz S Malik
{"title":"Clinical outcomes and complication rates following medial collateral ligament reconstruction using Achilles tendon allograft or hamstring tendon autograft: A systematic review.","authors":"Ross Sian, Abbas See, Tawfiq Alqeisi, Amit Meena, Stephen Dalgleish, Darren de Sa, Peter Davies, Peter D'Alessandro, Jimmy Ng, Shahbaz S Malik","doi":"10.1002/ksa.70625","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The medial collateral ligament (MCL) is the most commonly injured knee ligament, yet indications for reconstruction remain debated. Although consensus statements support allograft and hamstring autograft, comparative evidence regarding graft superiority is limited. This systematic review evaluated patient-reported outcome measures (PROMs) and complication rates following MCL reconstruction using Achilles tendon (AT) allograft or hamstring autograft.</p><p><strong>Methods: </strong>A systematic review was undertaken according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. PubMed, Cochrane, Google Scholar and Scopus were searched on 11th February 2026. Studies published within the previous 20 years that included patients aged ≥16 years undergoing MCL reconstruction with hamstring autograft or AT allograft and reporting clinical, functional and patient-reported outcomes were included. Data extraction and risk of bias assessment were performed. Due to heterogeneity, findings were narratively synthesised.</p><p><strong>Results: </strong>Sixteen studies were included: six AT allograft studies (n = 107; four using a bone block) and ten hamstring autograft studies (n = 275). Mean age was 33.9 and 31.3 years, with mean follow-up of 37 and 29.1 months, respectively. Mean postoperative international knee documentation committee (IKDC) and Lysholm scores were 81.1 and 86.8 for allograft and 78.8 and 87.2, respectively, for autograft. Three allograft and six hamstring autograft studies reported preoperative and postoperative PROMs, all demonstrated significant improvement (p < 0.05). Complication rates were 11.2% for AT allograft and 4.0% for hamstring autograft. AT allograft complications included two graft failures, four cases of residual asymptomatic valgus instability, three infections and three other complications. Hamstring autograft complications included one graft failure, four cases of asymptomatic valgus instability, three manipulations, one infection and two removals of hardware.</p><p><strong>Conclusion: </strong>Both AT allograft and hamstring tendon autograft significantly improve PROMs following MCL reconstruction. AT allografts demonstrated a numerically higher complication rate; however, the evidence is indirect and insufficient to determine the superiority of either graft type.</p><p><strong>Level of evidence: </strong>Level III.</p>","PeriodicalId":520702,"journal":{"name":"Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ksa.70625","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The medial collateral ligament (MCL) is the most commonly injured knee ligament, yet indications for reconstruction remain debated. Although consensus statements support allograft and hamstring autograft, comparative evidence regarding graft superiority is limited. This systematic review evaluated patient-reported outcome measures (PROMs) and complication rates following MCL reconstruction using Achilles tendon (AT) allograft or hamstring autograft.

Methods: A systematic review was undertaken according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. PubMed, Cochrane, Google Scholar and Scopus were searched on 11th February 2026. Studies published within the previous 20 years that included patients aged ≥16 years undergoing MCL reconstruction with hamstring autograft or AT allograft and reporting clinical, functional and patient-reported outcomes were included. Data extraction and risk of bias assessment were performed. Due to heterogeneity, findings were narratively synthesised.

Results: Sixteen studies were included: six AT allograft studies (n = 107; four using a bone block) and ten hamstring autograft studies (n = 275). Mean age was 33.9 and 31.3 years, with mean follow-up of 37 and 29.1 months, respectively. Mean postoperative international knee documentation committee (IKDC) and Lysholm scores were 81.1 and 86.8 for allograft and 78.8 and 87.2, respectively, for autograft. Three allograft and six hamstring autograft studies reported preoperative and postoperative PROMs, all demonstrated significant improvement (p < 0.05). Complication rates were 11.2% for AT allograft and 4.0% for hamstring autograft. AT allograft complications included two graft failures, four cases of residual asymptomatic valgus instability, three infections and three other complications. Hamstring autograft complications included one graft failure, four cases of asymptomatic valgus instability, three manipulations, one infection and two removals of hardware.

Conclusion: Both AT allograft and hamstring tendon autograft significantly improve PROMs following MCL reconstruction. AT allografts demonstrated a numerically higher complication rate; however, the evidence is indirect and insufficient to determine the superiority of either graft type.

Level of evidence: Level III.

采用同种异体跟腱或自体腘绳肌腱重建内侧副韧带的临床结果和并发症发生率:系统回顾。
目的:内侧副韧带(MCL)是最常见的膝关节韧带损伤,但重建指征仍有争议。虽然一致的声明支持同种异体移植物和腿筋自体移植物,但关于移植物优越性的比较证据有限。本系统综述评估了采用同种异体跟腱(AT)或自体腘绳肌移植重建MCL后患者报告的预后指标(PROMs)和并发症发生率。方法:根据系统评价和荟萃分析(PRISMA)指南的首选报告项目进行系统评价。PubMed, Cochrane, b谷歌Scholar和Scopus于2026年2月11日检索。过去20年内发表的研究包括年龄≥16岁的患者接受腘绳肌腱自体移植或AT异体移植的MCL重建,并报告了临床、功能和患者报告的结果。进行数据提取和偏倚风险评估。由于异质性,研究结果是叙述性综合的。结果:纳入16项研究:6项AT异体移植研究(n = 107; 4项使用骨块)和10项腿筋自体移植研究(n = 275)。平均年龄33.9岁、31.3岁,平均随访时间分别为37个月、29.1个月。术后国际膝关节文献委员会(IKDC)和Lysholm评分的平均值,同种异体移植为81.1分和86.8分,自体移植为78.8分和87.2分。3个同种异体移植和6个自体腘绳肌腱移植报告了术前和术后PROMs,均显示出显著改善(p结论:AT同种异体移植和自体腘绳肌腱移植均可显著改善MCL重建后PROMs。AT异体移植的并发症发生率较高;然而,证据是间接的,不足以确定任何一种移植物类型的优越性。证据等级:三级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书